+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 19 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating different dose levels of Brenipatide in adults with moderate-to-severe Chronic Obstructive Pulmonary Disease COPD. The study aims to assess the safety and effectiveness of Brenipatide compared to a placebo over approximately one year. This Phase 2 trial focuses on how the drug works alongside standard care in people with COPD who have a history of smoking and recent exacerbations. Participants are randomly assigned to receive either a low dose or high dose of Brenipatide or a placebo, all given by subcutaneous injection. All groups continue their standard care therapy, which may include long-acting bronchodilators or inhaled corticosteroids. The treatment period lasts 52 weeks, during which participants receive the study drug or placebo alongside their regular medications. Throughout the study, participants will have lung function tests measuring forced expiratory volume FEV1 before bronchodilator use at baseline and at several weeks up to week 52. Researchers will also monitor COPD exacerbation rates and quality of life using specific questionnaires. Safety and treatment effects are assessed regularly to understand how Brenipatide performs in managing COPD symptoms and lung function over one year.

Age: 40Years - 75YearsAll GendersPhase 2
127 locations
C

Actively Recruiting

Researchers are evaluating how well zenagamtide works and how safe it is compared to insulin glargine in people with type 2 diabetes who have a higher risk of heart and blood vessel problems. This study includes participants already taking 1 to 3 diabetes medications and aims to see if zenagamtide is not worse than insulin glargine in controlling blood sugar levels over one year. Participants are randomly assigned to receive either zenagamtide or insulin glargine. Zenagamtide is given once weekly as an injection under the skin in the thigh, abdomen, or upper arm using a pre-filled pen injector. Insulin glargine is given once daily as a subcutaneous injection in the same body areas, with rotation of the injection site. The study lasts for at least 52 weeks for primary outcomes, with cardiovascular events monitored for 104 weeks or more. During the study, participants will have regular assessments including blood tests for HbA1c, body weight measurements, waist circumference, blood pressure, cholesterol levels, and markers of inflammation. The main measure is the change in blood sugar control after 52 weeks. The study also tracks heart-related events and other health changes over two years. Participants will be monitored closely throughout the study period to evaluate safety and treatment effects.

Age: 45Years +All GendersPhase 3
330 locations
C

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the COMPASS Across Settings CAST intervention to improve goal setting and attainment skills for autistic youth transitioning from high school. Despite mandates for transition services in Individualized Education Programs IEPs, autistic students often face challenges achieving positive postsecondary outcomes. CAST integrates three evidence-based interventions with coaching support for caregivers, students, and employment specialists to better align goals across home, school, and community settings. CAST begins with a joint session involving the student, caregiver, special education teacher, and pre-employment transition specialist to discuss the students goals, strengths, and challenges related to social skills, communication, and work behaviors. This leads to tailored intervention plans followed by four one-hour coaching sessions incorporating performance feedback and instructional support. The project includes development, field testing, and a randomized controlled trial RCT to assess outcomes. Participants engage in focus groups, interviews, and a pilot RCT involving autistic youth, caregivers, teachers, and specialists. Outcomes measured include goal attainment of IEP progress, postsecondary goal achievement, intervention fidelity, transition plan quality, and organizational connectedness. Data collection occurs throughout the school year and up to one year after graduation, with additional analyses on service integration and cost. The study spans from initial development through post-school follow-up, lasting several years.

Age: 16Years - 99YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are evaluating the effects of vicadrostat combined with empagliflozin in adults who have type 2 diabetes, high blood pressure, and established cardiovascular disease but no history of heart failure. This study aims to understand if this combination can reduce the risk of cardiovascular events compared to a placebo combined with empagliflozin. Participation is randomized and double-blinded to compare these treatments fairly. Participants are randomly assigned to one of two groups one takes vicadrostat plus empagliflozin, and the other takes placebo tablets that look like vicadrostat plus empagliflozin. They take one tablet daily for a period ranging from two and a half years up to four years and three months. All participants continue their regular medications for diabetes, hypertension, and cardiovascular disease alongside the study treatments. Throughout the study, participants attend regular visits where their health is carefully monitored. Doctors collect information about cardiovascular events and take blood samples. They also track any side effects and changes in blood pressure and kidney function. The main outcome is the time until the first cardiovascular death or heart failure event, observed over up to 51 months. Participants stay in the study for up to four years and three months with ongoing health assessments.

Age: 18Years +All GendersPhase 3
1142 locations
S

Actively Recruiting

Healthy Volunteer

Researchers are studying vascular health in females with a normal body mass index BMI to understand how differences in body fat and muscle mass affect cardiovascular disease risk. This study focuses on females aged 18 to 50 who have a healthy BMI but may have varying body compositions. The goal is to evaluate resting vascular indicators and cardiovascular response to stress in this group. Participants will complete two separate study visits in a randomized order. During the high-fat meal trial, participants will fast, then consume two Jimmy Dean breakfast bowls high in fat, while vascular measurements and blood samples will be taken at baseline and multiple times after the meal. In the stress trial, participants will fast and then undergo a mental stress task, with vascular measurements and blood samples collected before and after the stress. Blood tests will measure factors like cholesterol, triglycerides, inflammatory markers, and epinephrine. Throughout the study, participants will have vascular assessments including flow-mediated dilation, pulse wave analysis, and pulse wave velocity. Blood will be drawn multiple times to analyze serum markers related to cardiovascular health and inflammation. Each vascular measurement requires resting quietly in a supine position. The study involves two main visits with detailed monitoring before and after interventions, and all data will be collected up to one year for ongoing analysis.

Age: 18Years - 50YearsFEMALEPhase Not Applicable
1 location
E

Actively Recruiting

Healthy Volunteer

Researchers are studying how consuming a fiber-enriched soda called Olipop before a high-fat meal affects heart and metabolism health compared to drinking a control beverage with the same calories and sugar. The study aims to understand post-meal cardiometabolic responses in healthy adults aged 18 to 50 without certain health conditions. Participants will take part in a crossover study where each person will consume both the prebiotic soda and the control drink on separate visits about a week apart. Each visit involves fasting overnight, drinking the assigned beverage, then eating a high-fat breakfast meal. Blood samples will be taken before and multiple times after the meal to measure various heart and metabolic biomarkers. During the study, participants will be monitored through physical measurements like weight and blood pressure, wear an activity tracker for several days, and keep a food record. The main outcomes include blood levels of triglycerides, glucose, insulin, and other markers over up to one year. The study includes a prescreening, a screening visit with consent and assessments, followed by two lab visits for the test meals and blood draws.

Age: 18Years - 50YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

Healthy Volunteer

Researchers are investigating how replacing table sugar with fresh mango sugar affects blood sugar, insulin, and vascular health after eating breakfast. The study focuses on adults with a body mass index BMI between 18.5 and 35.0 and explores the impact of sugar type in realistic meals on metabolic and vascular responses, which are important for diabetes and heart disease risk. Participants will take part in four meal trials in a randomized order, consuming breakfasts that are either high or low glycemic and sweetened with fresh mango or table sugar. The meals include corn flakes with 2% milk or steel cut oats with water, with sugar content and calories closely matched. Each trial involves blood sampling and artery dilation measurements before and after the meal, along with surveys on meal acceptability and satiety. Throughout the study, participants will have blood samples taken at multiple times up to three hours after eating to measure glucose, insulin, triglycerides, and HDL cholesterol. Artery dilation will be assessed at various times post-meal using flow-mediated dilation. Additional assessments include a one-time body composition and bone density scan. The study continues for up to 1.5 years to evaluate these effects comprehensively.

Age: 18Years - 45YearsAll GendersPhase Not Applicable
1 location
I

Actively Recruiting

Healthy Volunteer

Researchers are studying how a single high-fat meal affects gut, immune, and vascular health in people with metabolically healthy obesity and those with a normal weight but similar metabolic profiles. They also want to understand how taking a prebiotic fiber called inulin influences these health aspects in individuals with metabolically healthy obesity. This project includes two parts under one study approval, focusing on these specific groups and health markers. In part 1, participants with normal or obese body mass index BMI will complete a high-fat meal trial involving blood samples and vascular tests at multiple time points before and after the meal. The meal contains about 700 calories from fat, chocolate syrup, and protein powder. Part 2 involves only participants with obesity who will be randomized to receive either inulin supplements or a placebo for six weeks. Blood samples, stool samples, and vascular assessments will be collected at baseline and during follow-up visits. Participants will have various measurements taken, including blood tests to check biomarkers of inflammation and intestinal health, vascular function tests, and stool samples to analyze gut microbiome. Blood will be drawn multiple times within hours after the meal in part 1 and at intervals during the six-week supplement phase in part 2. The study will track changes in these markers over time to evaluate the impact of diet and supplementation on gut, immune, and vascular health. Participation may last up to two years for some outcome assessments.

Age: 18Years - 55YearsAll GendersPhase Not Applicable
1 location
E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating whether taking supplemental fiber for 9 weeks can improve vascular health in adults with obesity. They are also studying if the response differs between those with very few heart disease risk factors and those with several. This study focuses on individuals with a body mass index of 30 kgm2 or higher and groups them based on metabolic health status. Participants will consume inulin, a fiber supplement from chicory root, starting with 6 grams daily for one week, followed by 12 grams daily for eight weeks. They will dissolve the powder into a cool or room temperature beverage and drink it around the same time each day. The study includes assessments before starting, halfway through, and at the end of the intervention. During the study visits, participants will fast for about 10 hours before arriving in the morning. Researchers will collect blood samples and perform vascular tests including flow-mediated dilation and pulse wave velocity, along with body weight and composition measurements. Participants will also wear a blood pressure monitor for 24 hours and complete food records. Optional stool sample collection and special body scans will be done at the beginning and end of the study. The research team will monitor various blood markers and vascular health measures throughout the study, which lasts about 9 weeks.

Age: 18Years - 55YearsAll GendersPhase Not Applicable
1 location
M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations

1-10 of 19

1